Stryker Corp
NYSE:SYK
Net Margin
Stryker Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Stryker Corp
NYSE:SYK
|
150.4B USD |
12%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
232.7B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
191.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
157.6B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.3B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.6B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.9B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274.8B CNY |
31%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.5B USD |
26%
|
Stryker Corp
Glance View
Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Stryker Corp's most recent financial statements, the company has Net Margin of 12.3%.
You don't have any saved screeners yet